SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Significant Increase in Short Interest
SAB Biotherapeutics, Inc. (NASDAQ:SABS - Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 901,471 shares, a...